Floatz logo

Asparaginase

Leukemia

Gruppo Italiano Malattie EMatologiche dell'Adultoprotein_peptidePhase 3Dormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
72/ 100
Competitive Position
65/ 100

Competitive context

124 Active assets in the Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BB
Vincristine sulfate
Inhye Ahn
Phase 3BB
MERCAPTOPURINE ANHYDROUS
Dana-Farber Cancer Institute
Phase 3BB
BUSULFANUM
National Cancer Institute (NCI)
Phase 4BB
PEGASPARGASE
Dana-Farber Cancer Institute
Phase 3BB

View all 50 →

Same molecule, other indications

Asparaginase is also rated in:

adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
78 / 100
View asset →
childhood acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 3
72 / 100
View asset →
acute lymphoblastic leukemiaActive
BB
Indicative · Phase 4
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →